These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 27115415)

  • 1. Glucagon: acute actions on hepatic metabolism.
    Miller RA; Birnbaum MJ
    Diabetologia; 2016 Jul; 59(7):1376-1381. PubMed ID: 27115415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon action in the brain.
    Abraham MA; Lam TKT
    Diabetologia; 2016 Jul; 59(7):1367-1371. PubMed ID: 27115416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon is the key factor in the development of diabetes.
    Lee YH; Wang MY; Yu XX; Unger RH
    Diabetologia; 2016 Jul; 59(7):1372-1375. PubMed ID: 27115412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of leptin in diabetes: metabolic effects.
    Meek TH; Morton GJ
    Diabetologia; 2016 May; 59(5):928-32. PubMed ID: 26969486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic glucose and lipid metabolism.
    Jones JG
    Diabetologia; 2016 Jun; 59(6):1098-103. PubMed ID: 27048250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleotropic effects of leptin to reverse insulin resistance and diabetic ketoacidosis.
    Perry RJ; Petersen KF; Shulman GI
    Diabetologia; 2016 May; 59(5):933-7. PubMed ID: 26961503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple benefits of targeting inflammation in the treatment of type 2 diabetes.
    Donath MY
    Diabetologia; 2016 Apr; 59(4):679-82. PubMed ID: 26868493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipids and immunoinflammatory pathways of beta cell destruction.
    Imai Y; Dobrian AD; Morris MA; Taylor-Fishwick DA; Nadler JL
    Diabetologia; 2016 Apr; 59(4):673-8. PubMed ID: 26868492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gestational diabetes mellitus and long-term consequences for mother and offspring: a view from Denmark.
    Damm P; Houshmand-Oeregaard A; Kelstrup L; Lauenborg J; Mathiesen ER; Clausen TD
    Diabetologia; 2016 Jul; 59(7):1396-1399. PubMed ID: 27174368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon, a key factor in the pathophysiology of type 2 diabetes.
    Girard J
    Biochimie; 2017 Dec; 143():33-36. PubMed ID: 29024725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MST1: a promising therapeutic target to restore functional beta cell mass in diabetes.
    Ardestani A; Maedler K
    Diabetologia; 2016 Sep; 59(9):1843-9. PubMed ID: 27053234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of dysregulated glucagon secretion in type 2 diabetes.
    D'Alessio D
    Diabetes Obes Metab; 2011 Oct; 13 Suppl 1():126-32. PubMed ID: 21824266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 100 years of glucagon and 100 more.
    Wewer Albrechtsen NJ; Holst JJ; Cherrington AD; Finan B; Gluud LL; Dean ED; Campbell JE; Bloom SR; Tan TM; Knop FK; Müller TD
    Diabetologia; 2023 Aug; 66(8):1378-1394. PubMed ID: 37367959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of the liver in the regulation of glucose metabolism in diabetes and chronic liver disease].
    Cotrozzi G; Casini Raggi V; Relli P; Buzzelli G
    Ann Ital Med Int; 1997; 12(2):84-91. PubMed ID: 9333317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renaissance of leptin for obesity therapy.
    Quarta C; Sánchez-Garrido MA; Tschöp MH; Clemmensen C
    Diabetologia; 2016 May; 59(5):920-7. PubMed ID: 26983921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is it worth treating gestational diabetes: if so, when and how?
    Vääräsmäki M
    Diabetologia; 2016 Jul; 59(7):1391-1395. PubMed ID: 27168136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of type 2 diabetes on the regulation of hepatic glucose metabolism.
    Basu A; Shah P; Nielsen M; Basu R; Rizza RA
    J Investig Med; 2004 Sep; 52(6):366-74. PubMed ID: 15612449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The constitutive activation of Egr-1/C/EBPa mediates the development of type 2 diabetes mellitus by enhancing hepatic gluconeogenesis.
    Shen N; Jiang S; Lu JM; Yu X; Lai SS; Zhang JZ; Zhang JL; Tao WW; Wang XX; Xu N; Xue B; Li CJ
    Am J Pathol; 2015 Feb; 185(2):513-23. PubMed ID: 25438063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiology of the pancreatic alpha-cell and glucagon secretion: role in glucose homeostasis and diabetes.
    Quesada I; Tudurí E; Ripoll C; Nadal A
    J Endocrinol; 2008 Oct; 199(1):5-19. PubMed ID: 18669612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial network regulation and its potential interference with inflammatory signals in pancreatic beta cells.
    Baltrusch S
    Diabetologia; 2016 Apr; 59(4):683-7. PubMed ID: 26873508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.